IQVIA Patient Suite

IQVIA Patient Suite is a clinical trial technology platform designed to improve patient engagement, simplify trial operations, and support better patient outcomes. It is intended for life sciences organisations running clinical trials across phases and therapeutic areas, offering an integrated set of tools that connect electronic clinical outcome assessments, consent processes, randomisation and trial supply management, and connected device data within a single environment.

The suite brings together several distinct product components — eCOA, eConsent, IRT, and connected devices — under a unified patient-facing and operations-facing framework. By consolidating these functions, the platform aims to reduce the operational complexity that typically arises when separate systems are used for each function, while also improving the experience for trial participants.

Core Components

• Electronic Clinical Outcome Assessment (eCOA): Supports the collection of patient-reported, clinician-reported, and observer-reported outcomes electronically, replacing paper-based data collection in clinical trials.
• eConsent: Provides electronic informed consent capabilities, enabling patients to review, understand, and sign consent documentation digitally as part of the trial onboarding and ongoing participation process.
• Interactive Response Technology (IRT): Manages randomisation and trial supply, supporting the allocation of patients to treatment arms and the logistics of investigational product distribution.
• Connected Devices: Integrates data from wearable and remote monitoring devices, enabling passive and active data capture from patients outside of clinical site visits.

Patient Engagement Capabilities

• Supports patient recruitment and engagement throughout the study lifecycle.
• Provides tools designed to improve the patient experience during trial participation, with the goal of supporting retention and compliance.
• Enables remote and decentralised trial participation through connected device integration and electronic data capture.
• Offers a patient-facing interface that consolidates consent, outcome reporting, and study communications.

Operational and Trial Management Features

• Integrates eCOA, eConsent, IRT, and device data within a single platform to reduce the burden of managing multiple disconnected systems.
• Supports study execution across clinical trial phases, from early phase through Phase IIb/III studies.
• Designed to work alongside IQVIA's broader clinical technology ecosystem, including the Site Suite and Clinical Trial Financial Suite, as part of IQVIA's connected clinical trial technology portfolio.
• Contributes to faster decision-making by consolidating patient data streams into a unified data environment.

Integration and Platform Context

• Patient Suite is part of IQVIA's wider Technologies portfolio, which also includes Site Suite, Safety Suite, and Quality Management and Regulatory Suite.
• The platform is positioned within IQVIA's broader Research and Development solutions, which span patient and site centric solutions, functional services, and global laboratories.
• IQVIA's AI capabilities, including the IQVIA.ai Platform and Healthcare-grade AI, are available across the technology portfolio and may be applied within clinical trial workflows supported by Patient Suite.

Patient Suite is available globally, consistent with IQVIA's operations across the Americas, Europe, Asia Pacific, and Middle East and Africa regions. It is designed for use by pharmaceutical manufacturers, emerging biopharma organisations, and other life sciences sponsors conducting clinical trials across a broad range of therapeutic areas.